A Pharmacogenetic Study of Aldehyde Oxidase I in Patients Treated With XK469

Pharmacogenetics and Genomics - United States
doi 10.1097/fpc.0000000000000023
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Azoreductase Activity of Liver Aldehyde Oxidase.

Chemical and Pharmaceutical Bulletin
MedicineDrug DiscoveryChemistry
1983English

Involvement of Liver Aldehyde Oxidase in Sulfoxide Reduction.

Chemical and Pharmaceutical Bulletin
MedicineDrug DiscoveryChemistry
1982English

Chiari I Malformation Associated With Syringomyelia: A Retrospective Study of 316 Surgically Treated Patients

Spinal Cord
MedicineNeurologyRehabilitation
2007English

A Phase I Study of Intravenous Aflibercept With FOLFIRI in Japanese Patients With Previously Treated Metastatic Colorectal Cancer

Investigational New Drugs
OncologyPharmacology
2012English

Dietary, Lifestyle and Pharmacogenetic Factors Associated With Arteriole Endothelial-Dependent Vasodilatation in Schizophrenia Patients Treated With Atypical Antipsychotics (AAPs)

Schizophrenia Research
PsychiatryMental HealthBiological Psychiatry
2011English

Purification of the Aldehyde Oxidase Homolog 1 (AOH1) Protein and Cloning of theAOH1and Aldehyde Oxidase Homolog 2 (AOH2) Genes

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2001English

Interaction of 2-Thio-4-Oxo-Quinazoline Derivatives With Guinea Pig Liver Molybdenum Hydroxylases, Xanthine Oxidase and Aldehyde Oxidase

Journal of Biological Sciences
Molecular MedicineCell Biology
2005English

Figure 4: Effect of Mackerel Muscle Protein Hydrolysate on Aldehyde Oxidase and Xanthine Oxidase Activity in Liver.

English

A Phase I Study of Indoximod in Patients With Advanced Malignancies

Oncotarget
Oncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy